Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy

- Wong-Brown, Michelle W., van der Westhuizen, Andre, Bowden, Nikola A.

Biomarkers of platinum resistance in ovarian cancer: What can we use to improve treatment

- Van Zyl, Belinda, Tang, Denise, Bowden, Nikola A.

Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma

- Budden, Timothy, van der Westhuizen, Andre, Bowden, Nikola A.

The role of nucleotide excision repair in melanoma development and platinum chemotherapy resistance

- Budden, Timothy

Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?

- Bowden, Nikola A.

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

- Wagner, U., Marth, C., Gebski, V., Lauraine, E. P., Largillier, R., Kaern, J., Brown, C., Heywood, M., Bonaventura, T., Vergote, I., Piccirillo, M. C., Fossati, R.